My clinical practice is limited to caring for patients with brain and spinal cord tumors as a member of the multidisciplinary Brain Tumor Program. Our team includes specialists in Neuro-Oncology, Neurology, Neurosurgery, Radiation Oncology, and Neuropsychology along with skilled nurse practitioners. There is a broad spectrum of expertise that The Children's Hospital of Philadelphia brings to treating its patients with brain tumors.
Treating cancer is a team effort at Children's Hospital, and we consider patients and their families as part of the team. Since our young patients are dependent on their parents for medical decision-making, I try to give them a sense of some control over their disease, communicating in an age appropriate manner. Kids do much better when they are part of the treatment plan and "secrets" are not kept from them.
My research is focused on developing personalized and targeted therapeutics in tumors of the nervous system and understanding the late effects of our therapies in long-term survivors.
As part of our approach to identifying new treatments for children with brain tumors, we are members of the multi-institutional Pacific Pediatric Neuro-Oncology Consortium (PNOC) and a Children's Oncology Group (COG) Phase 1 Institution. These groups are involved in early phase clinical trials for relapsed and refractory brain tumors, with a particular focus on testing new, targeted treatments in children with brain tumors.
Our Children's Hospital team has partnered with drug development groups, and we are rapidly identifying drugs that show promise in patients with brain tumors who have no other curable option. There is a sense of urgency in our group — working collaboratively with laboratory scientists and drug development companies on rational, biologically-based therapies.
There is huge progress in getting promising drugs to children with cancer. Through our cooperative group consortia, the pace is much more rapid than in past years, and Children's Hospital is a major part of the effort to help bring new agents to children with brain tumors.
Education and Training
MD - Yale University School of Medicine, New Haven, CT
Pediatrics - The Children’s Hospital, Boston, MA
Pediatrics - The Children's Hospital, Boston, MS
Hematology/Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pa.
Hematology-OncologyPediatrics – American Board of Pediatrics
University of Southern California (BS, psychobiology), Los Angeles, Calif.
PhD in Neurobiology - Yale University, New Haven, CT
MPhil - Yale University, New Haven, CT
Titles and Academic Titles
Medical Director for Oncology, International Patient Services
Clinical Associate Professor, Perelman School of Medicine at the University of Pennsylvania
Departments and Services
Areas of Focus
Shah AC, Cole KA, Waanders AJ, Minturn JE, Fisher MJ, Hill-Kayser C. Proton radiation therapy effect mimicking radiologic relapse in two young adults with pure CNS germinoma. Pediatric Blood and Cancer, 2015 (in review).
Frick M, Minturn JE, Li Y, Hill-Kayser CE. Radiotherapy-related outcomes in pediatric patients with atypical teratoid rhabdoid tumor of the central nervous system. Journal of Pediatric Hematology/Oncology, 2015 (in review).
Shah AC, Minturn JE, Li Y, Belasco JB, Phillips PC, Kang TI, Cole KA, Waanders AJ, Pollack R, Didomenico C, Wildes C, Fisher MJ. Carboplatin rechallenge after hypersensitivity reactions in pediatric patients with low-grade glioma. Pediatric Blood and Cancer, 2015 (in press).
Hoffman L, Bartels U, Miles L, Hawkins C, Goldman S, Leary S, Hassal T, Minturn J, Packer R, Foreman N, Warren K, Broniscer A, Broxon E, Shih C-S, Leach J, Jones B, Baugh J, Hacker B, Lerme B, Jones C, Savage S, Kirkendall J, Doughman R, Wollman M, Millett L, O’Keefe R, Bouffet E, van Vuurden D, Fouladi M. Clinical, radiographic, and biologic characteristics of long-term survivors of diffuse intrinsic pontine glioma. 3rd Biennial Conference on Pediatric Neuro-Oncology Basic and Translational Research, May 7-8, 2015. San Diego, CA.
Hollander A, Lustig RA, Tochner Z, Paltin I, Both S, Zhai H, Fisher MJ, Minturn JE, Phillips P, Hill-Kayser CE. Acute toxicities and treatment outcomes for pediatric medulloblastoma patients treated with proton-based craniospinal irradiation. 46th Congress of the International Society of Paediatric Oncology, October 22-25, 2014. Toronto, Canada.
Paltin I, Hill-Kayser CE, Lustig RA, Minturn JE, Fisher MJ. Relative differences in risk for neuropsychological late effects post proton radiation for infratentorial versus supratentorial pediatric brain tumors. 46th Congress of the International Society of Paediatric Oncology, October 22-25, 2014. Toronto, Canada.
Hill-Kayser CE, Tochner Z, Fisher M, Minturn JE, Belasco J, Bagatell R, Balamuth N, Womer R, Reilly A, Phillips P, Lustig RA. Proton radiation for treatment of children less than 18 months of age. 46th Congress of the International Society of Paediatric Oncology, October 22-25, 2014. Toronto, Canada.
Hollander A, Both S, Zhai H, Lustig RA, Tochner Z, Fisher MJ, Minturn JE, Phillips P, Hill-Kayser CE. Acute toxicities and treatment outcomes of a novel craniospinal irradiation (CSI) technique using double scattered proton therapy for medulloblastoma patients. ASTRO’s 56th Annual Meeting, September 14-17, 2014. San Francisco, CA.
Hill-Kayser CE, Lustig RA, Minturn JE, Both S, Waanders AJ, Belasco JB, Armstrong C, Phillips PC, Fisher MJ. Outcomes after proton radiotherapy (RT) for infratentorial brain tumors in infants and very young children. 16th International Symposium on Pediatric Neuro-Oncology, 28 June-02 July 2014. Singapore.
Hill-Kayser CE, Paltin I, Lustig RA, Fisher MJ, Both S, Belasco JB, Cole KA, Waanders AJ, Phillips PC, Minturn JE. Proton radiation for treatment of localized ependymoma in children. 16th International Symposium on Pediatric Neuro-Oncology, 28 June-02 July 2014. Singapore.
Paltin I, Hill-Kayser CE, Lustig RA, Fisher MJ, Belasco JB, Phillips PC, Cole KA, Minturn JE. Neuropsychological functioning after proton radiation therapy for pediatric ependymoma. 12th Annual American Academy of Clinical Neuropsychology Conference, June 25-28, 2014. New York, NY.
Hill-Kayser CE, Lustig RA, Minturn JE, Both S, Waanders AJ, Belasco JB, Armstrong CA, Phillips P, Fisher MJ. Proton radiation for treatment of infratentorial brain tumors in infants and very young children. 2014 ASCO Annual Meeting, May 30-June 3, 2014. Chicago, IL.
Hill-Kayser CE, Paltin I, Lustig RA, Fisher MJ, Both S, Belasco JB, Cole KA, Waanders AJ, Phillips P, Minturn JE. Outcomes after proton radiotherapy for localized childhood ependymoma (EP). 2014 ASCO Annual Meeting, May 30-June 3, 2014. Chicago, IL.
Meany HJ, Dome J, Hinds PS, Bagatell R, Shusterman S, Widemann BC, Stern E, London WB, Kim A, Fox E, Rodriguez-Galindo C, Minturn JE. Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors. 2014 ASCO Annual Meeting, May 30-June 3, 2014. Chicago, IL.
Doolin E, Redden RA, Brodeur GM, Minturn JE, Iyer R. Use of a microgravity culture system to assess biological behavior in neuroblastoma (NB) cell lines. 99th Clinical Congress, American College of Surgeons, October 6-10, 2013. Washington, D.C.
Paltin I, Minturn J, Fisher M, Barakat L. Prospective case study of two 2 year olds with posterior fossa ependymoma treated with proton radiation therapy. American Academy of Clinical Neuropsychology, June 19-22, 2013. Chicago, IL.
Minturn JE and Fisher MJ: Brain Tumors, In: Schwartz MW (ed), The 5-Minute Pediatric Consult, 7th Edition, Philadelphia: Wolters Kluwer, 2015, p.124-125.
Zhi W, Minturn J, Rappaport E, Brodeur G, Li H: Network-based analysis of multivariate gene expression data. In: Statistical Methods for Microarray Data Analysis, vol 972, Yakovlev AY, Klebanov L, and Gaile D, (eds). Humana Press, Totowa, NJ, Pp. 121-139, 2013.
Minturn JE: Teratoma, In Schwartz MW (ed), The 5-Minute Pediatric Consult, 6th Edition, Lippincott Williams & Wilkins, Philadelphia, PA. Pp. 864-865, 2012.
Sievert AJ, Minturn JE. Brain tumors. In: Florin TA, Ludwig S, editors. Netter's pediatrics. Philadelphia: Elsevier Publishing; 2011.
Fisher MJ, Minturn J, Phillips PC. Brain tumors. In: Brodeur GM, Manno CS, editors. Pediatric hematology/oncology: the requisites in pediatrics. Philadelphia: C.V. Mosby Publishing; 2008.
Minturn JE. Teratoma. In: Schwartz MW, editor. The 5-minute pediatric consult. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 840-41.
Minturn JE. Teratoma. In: Schwartz MW, editor. The 5-minute pediatric consult. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 834-35.
Minturn JE, Friedman DL. Teratoma. In: Schwartz MW, editor. The 5-minute pediatric consult. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 812-13.
Minturn JE. Idiopathic thrombocytopenic purpura. In: Schwartz MW, editor. The 5-minute pediatric consult. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 464-65.
Minturn JE, Kelly KM. Hemophilia. In: Schwartz MW, editor. The 5-minute pediatric consult. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 420-21.
Minturn JE, Kelly KM. Aplastic anemia. In: Schwartz MW, editor. The 5-minute pediatric consult. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 130-31.
Posters and Presentations
From the Office through Treatment and Survivorship: Pediatric Brain Tumors. CME Lecture Series in Pediatric Oncology, Bridgewater NJ, March 2015.
Neurocognitive effects of brain tumor therapy in children. Pediatric Brain Tumor Foundation, Valley Forge Christian College, Phoenixville, PA, September 2014.
Advances in Precision Medicine for Pediatric Brain Tumors. Pediatric Brain Tumor Foundation Annual Ride for Kids Program, Valley Forge Christian College, Phoenixville, PA, September 2013.
Awards and Honors
2010, Hyundai Hope on Wheels, Hope Grant Award Winner
2010, Advances in Neuroblastoma Research Annual Meeting: Best Clinical Poster Award, Stockholm, Sweden
2006-2009, American Cancer Society Mentored Research Scholar Grant
2004-2006, Wolfson Scholar in Neuroblastoma Research
2003-2006, American Society of Clinical Oncology Career Development Award
2003, Florence R.C. Murray Program Fund Award
2002-2003, American Society of Clinical Oncology Young Investigator Award
2000, Selected Participant, American Association for Cancer Research Workshop, Molecular Biology in Clinical Oncology, The Given Institute, Aspen, CO
1989-1996, Pre-doctoral Fellowship, Howard Hughes Medical Institute
1988, Medical Student Research Fellowship, American Heart Association
1986, 1986 Phi Kappa Phi, University of Southern California
1986, 1986 Phi Beta Kappa, University of Southern California
1986, 1986 Summa Cum Laude, University of Southern California
Editorial and Academic Positions
Clinical Cancer Research
Journal of Neuro-Oncology
Pediatric Blood & Cancer
Neuropsychiatric Disease and Treatment
Academic and Institutional Committees
2015-present, Oncology Liaison, International Medicine
2013-present, Clinical Competency Committee
2011-present, Targeted Therapy Glioma Group
2010-present, Proton Therapy Triage Committee
2008-present, Pediatric Protocol Review Committee
2006-present, Pediatrics Residency Program Faculty Interviewer
Leadership and Memberships
Memberships in Professional Organizations
American Association for Cancer Research
American Society of Clinical Oncology
American Society of Pediatric Hematology/Oncology
Children’s Oncology Group (COG)
Pediatric Brain Tumor Consortium
Institutional Principal Investigator
Society for Neuro-Oncology
Pacific Pediatric Neuro-Oncology Consortium
- Institutional Principal Investigator
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.